Moore K, Colombo N, Scambia G, et al. Olaparib maintenance therapy following first-line platinum-based chemotherapy in patients with FIGO stage III–IV ovarian cancer (OC) with a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial. ESMO 2018, abstract LBA7_PR.
NFK: zelfs 10 jaar na diagnose kanker nog steeds klachten
feb 2024 | Borstkanker, Leukemie, Lymfoom, Uro-oncologie